Commercial Successes
Pfizer has the vision, experience, and resources to complement your assets and bring new innovations to market. Together, we can pursue a broad array of scientific therapies and advance sound science into therapeutic breakthroughs.
An alliance with Pfizer can provide you with access to proven sales expertise and marketing know-how to complement your own internal capabilities. Our sales, marketing, manufacturing, and managed care organizations have a record of unparalleled success. In addition, we have a leading track record of leveraging pharmaceutical product success through effective life-cycle management.
Pfizer has:
- 11 products currently with sales of more than $1 billion.
- 14 products currently ranked at the top of their respective therapeutic areas.
- A proven history of establishing new therapeutic market opportunities—such as ARICEPT® (donepezil HCl) and VIAGRA® (sildenafil citrate).
Many of our top-selling products began with collaborations. These include:
Pfizer's global sales force drives our success in every major market around the world. We possess one of the largest and most respected field forces in the industry—ranked #1 by United States physicians for an unprecedented 13 consecutive years.
With 28,000 members worldwide, we can provide a distinct global market research advantage for your asset. The experience and commitment of our team—including our top ranked primary care field force—speaks to Pfizer's ability to successfully navigate the increasingly complex world of pharmaceutical sales.
We possess one of the largest and most respected field forces in the industry—ranked #1 by United States physicians for an unprecedented 13 consecutive
years.
Through our strong working relationships with several managed-care organizations, Pfizer can best ensure that patients have access to innovative medicines and quality health care. And, our trusted relationships with payers—coupled with modern actuarial models—can provide broad access and ensure commercial success for your product.
We're knowledgeable in managed care negotiation, and have a successful track record implementing and supporting contracts for both branded and generic pharmaceutical products. Our proven expertise ranks high with managed-care medical directors in areas such as corporate approach and disease management.
Our trusted relationships with payers—coupled with modern actuarial models—can provide broad access and ensure commercial success for your product.
SPIRIVA® (tiotropium bromide inhalation powder)—Boehringer Ingelheim
Available in more than 55 nations, SPIRIVA is now the most prescribed branded medication for chronic obstructive pulmonary disease (COPD) worldwide. Since its introduction in 2002, SPIRIVA has helped more than 7.6 million people with COPD to breathe better. Pfizer co-promotes SPIRIVA with Boehringer Ingelheim, which discovered and developed the medication.
ARICEPT® (donepezil HCl)—Eisai Co., Ltd.
As the top-selling medicine in the Alzheimer's disease market, the success of ARICEPT has been built on more than 15 years of clinical evidence supporting its efficacy and tolerability. ARICEPT is now the only medicine approved in the U.S. to treat mild, moderate, and severe forms of Alzheimer's disease. Pfizer co-promotes ARICEPT with its discoverer and developer, Eisai Co., Ltd., and is active in its continued development.
- Contact Us
- Investors
- Sitemap
- Careers
- Business to Business
- Terms of Use
- Global Network
- Privacy Policy
Copyright © 2002–2010 Pfizer Inc. All rights reserved. This information is intended only for residents of the United States. The product information provided in this site is intended only for residents of the United States. The products discussed herein may have different product labeling in different countries. Pfizer Inc is a pharmaceutical company committed to helping people improve their health by discovering and developing medicines.
